William Sullivan, Former President & CEO BW USA

Joined company as General Counsel in 1973 and became President in 1981.

Topics covered include:

* corporate culture

* management of research

* management style

* pricing, generally and specifically of Retrovir and Lanoxin

* marketing, generally approach to and development of, looking at Sudafed and Actifed specifically

* legal case regarding building in Research Triangle Park, North Carolina

* Drug Regulation and the FDA [Food and Drug Administration]

* Patents

* strategic review of the company including the McKinsey Report

* relationship between UK and US companies

* possible Joint Venture with Gillette

* flotation

23 Apr 2001

2 audio tapes and transcript Tape 6

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.